The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gluck Frederick W since 2006.
The trader's CIK number is 1184126.
At the time of the last reporting, Gluck Frederick W was the Director of Cytomx Therapeutics, Inc.. (stock ticker symbol CTMX).
Also see all insider trading activities at Cytomx Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | CTMX | 0 | $0 | 35,000 | $1,009,752 | 0 | $0 |
2017 | CTMX | 0 | $0 | 25,000 | $513,630 | 0 | $0 |
2016 | CTMX | 0 | $0 | 0 | $0 | 93,124 | $118,826 |
2015 | CTMX | 15,000 | $180,000 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2010 | AMGN | 0 | $0 | 1,600 | $83,292 | 0 | $0 |
2009 | AMGN | 0 | $0 | 16,000 | $852,896 | 16,000 | $463,488 |
2006 | AMGN | 4,705 | $350,423 | 0 | $0 | 0 | $0 |
1. Cytomx Therapeutics, Inc. (CTMX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-03-26 | CTMX | Sale | 5,000 | 31.93 | 159,640 |
2018-03-02 | CTMX | Sale | 16,181 | 30.00 | 485,462 |
2018-02-28 | CTMX | Sale | 3,819 | 30.00 | 114,570 |
2018-01-05 | CTMX | Sale | 10,000 | 25.01 | 250,080 |
2017-12-26 | CTMX | Sale | 5,000 | 22.29 | 111,425 |
2017-10-04 | CTMX | Sale | 10,000 | 24.27 | 242,680 |
2017-09-26 | CTMX | Sale | 5,000 | 17.30 | 86,475 |
2017-06-26 | CTMX | Sale | 5,000 | 14.61 | 73,050 |
2016-08-09 | CTMX | Option Ex | 93,124 | 1.28 | 118,826 |
2015-10-14 | CTMX | Buy | 15,000 | 12.00 | 180,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2010-09-08 | AMGN | Sale | 800 | 52.36 | 41,888 |
2010-08-26 | AMGN | Sale | 800 | 51.76 | 41,404 |
2009-01-27 | AMGN | Option Ex | 16,000 | 28.97 | 463,488 |
2009-01-27 | AMGN | Sale | 16,000 | 53.31 | 852,896 |
2006-02-17 | AMGN | Buy | 4,705 | 74.48 | 350,423 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gluck Frederick W (Director of Cytomx Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.